Arbutus Biopharma (ABUS) BidaskScore is lowered to Held

Arbutus Biopharma

The BidaskScore of Arbutus Biopharma ABUSABUS shows that the shares of the company are now ABUSStrongly Bought Held by investors.

The BidaskScore of the BiotechnologyBiotechnology shows that the sector is BiotechnologyStrongly Bought Held since March 5.

Here are the BidAskScore of other related companies in the Biotechnology sector:

Arbutus Biopharma Corp. is a biopharmaceutical company. It focuses on discoveringˌ developing and commercializing a cure for patients suffering from chronic HBV infectionˌ a liver disease caused by the hepatitis B virus. The company was founded on October 6ˌ 2005 and is headquartered in Burnabyˌ Canada.

Arbutus Biopharma

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.